BenzingaAugust 7, 2026 at 9:16 AM NY28 days ago

Piper Sandler Reiterates Overweight on Steris, Raises Price Target to $275

Piper Sandler analyst Jason Bednar reiterates Steris (NYSE:STE) with a Overweight and raises the price target from $270 to $275.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Benzinga

Companies in This Story